SCHEMBL14420428

SCHEMBL14420428

Fc1ccc2c(c1)C(CCNCl)c1ccccc1CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 10/20 0.43
HRH1 P35367 7/20 0.43
RET P07949 1/20 0.41
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
HTR1A P08908 1/20 0.36
SLC6A4 P31645 1/20 0.36
HTR7 P34969 1/20 0.36
HTR2B P41595 1/20 0.36
HTR2C P28335 2/20 0.35
PRCP P42785 1/20 0.35
PIN1 Q13526 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
DHODH Q02127 1/20 0.34
CHRM1 P11229 1/20 0.34
ADRA2B P18089 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14420427 0.93 HTR2A (0.40) HTR2AHRH1SLC6A4HTR2CHTR1D
SCHEMBL14415682 0.81 HTR2A (0.58) HTR2AHRH1RETDRD2DRD3
Hydrochloric Acid SCHEMBL5518011 0.80 HTR2A (0.57) HTR2AHRH1RETDRD2DRD3
SCHEMBL13867298 0.78 HTR2A (0.63) HTR2AHRH1RETDRD2DRD3
SCHEMBL14415683 0.72 HTR2A (0.44) HTR2AHRH1RETSLC6A4HTR2B
Hydrochloric Acid SCHEMBL5517302 0.71 HTR2A (0.43) HTR2AHRH1RETSLC6A4HTR2B
SCHEMBL11822622 0.71 PIN1 (0.46) HTR2ARETHTR2CPRCPPIN1
SCHEMBL14415680 0.69 HTR2A (0.43) HTR2AHRH1RETDRD2DRD3
SCHEMBL5514752 0.69 HTR2A (0.40) HTR2ASLC6A4HTR2CHTR1DHTR1B
SCHEMBL11722433 0.68 HTR2A (0.63) HTR2AHRH1RETDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268166-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2007-09-11 US disclosed